LifeSci Venture Partners is the early-stage investing arm of LifeSci Partners, a life sciences and healthcare consultancy. Founded in 2017 and based in New York, the firm invests in innovative biopharma, medical device, and health technology companies, partnering with entrepreneurs, clinicians, and scientists to provide founder-aligned capital.
41% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-b (43% of deals). Average disclosed round size is $80.8M (across 34 rounds with reported amounts).
Portfolio
24
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
37 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Serapha Bio | Series A | $138M | Jan 2026 |
 VeraDermics | Series C | — | Oct 2025 |
 Brainomix | Series C | $18M | Mar 2025 |
 Averto Medical | Series A | $30.5M | May 2024 |
 ProfoundBio | Series B | $112M | Feb 2024 |
 MOMA Therapeutics | Series B | $150M | May 2022 |
 Beta Bionics | Series C | $57M | Feb 2022 |
| MOMA Therapeutics | Series B | $150M | Jan 2022 |
| AAntios Therapeutics, Inc. | Series B | $75M | Nov 2021 |
| AAntios Therapeutics, Inc. | Series A | $75M | Nov 2021 |
| CClade | Unknown | $87M | Nov 2021 |
| AAntios Therapeutics, Inc. | Series B | $96M | Apr 2021 |
 Iridia | Growth | — | Jan 2021 |
| Iridia | Series B | $24M | Jan 2021 |
| AAntios Therapeutics, Inc. | Series B | $96M | Jan 2021 |
| CClade | Series A | $87M | Jan 2021 |
 Cala Health | Series C | $50M | Jan 2021 |
 RayzeBio | Series C | $108M | Jan 2021 |
| CCentessa | Series A | $250M | Jan 2021 |
 Orasis Pharmaceuticals | Series B | $13M | Sep 2020 |
 Science 37 | Series B | $40M | Aug 2020 |
| AAthira | Series B | $85M | Jun 2020 |
 Athira Pharma | Series B | $85M | Jun 2020 |
| Orasis Pharmaceuticals | Series C | $30M | Jan 2020 |
 Orasis | Series C | $30M | Jan 2020 |
Page 1 of 2
Top Co-Investors
Cormorant Asset Management7 shared
Logos Capital7 shared
Redmile Group6 shared
RA Capital Management6 shared
Viking Global Investors5 shared
The Invus Group, LLC5 shared
Soleus Capital5 shared
GV5 shared
Lux Capital5 shared
Rock Springs Capital5 shared
Scale Venture Partners4 shared
Perceptive Advisors4 shared
Pontifax4 shared
Adage Capital Management4 shared
Delos Capital4 shared
Sixty Degree Capital4 shared
Amzak Health4 shared
Alexandria Venture Investments4 shared
Novartis Venture Fund4 shared
Last updated: 7 October 2026